𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan

✍ Scribed by Michael Halank; Martin Kolditz; Stephan Miehlke; Steffen Schiemanck; Alexander Schmeisser; Gert Hoeffken

Book ID
106324136
Publisher
Springer Vienna
Year
2005
Tongue
German
Weight
68 KB
Volume
155
Category
Article
ISSN
0043-5341

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety and efficacy of combined use of s
Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension
✍ Mark J. Austin; Neil I. McDougall; Julia A. Wendon; Elizabeth Sizer; Alex S. Kni πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 103 KB

Portopulmonary hypertension (PPHTN) represents a constrictive pulmonary vasculopathy in patients with portal hypertension. Liver transplantation (LT) may be curative and is usually restricted to patients with mild-to-moderate disease severity characterized by a mean pulmonary artery pressure (mPAP <

Long-term iloprost infusion therapy for
Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases
✍ Jose De La Mata; Miguel A. Gomez-Sanchez; Mercedes Aranzana; Juan J. Gomez-Reino πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 613 KB

Objective. To determine the effects of short-term, maximum-tolerated-dose and long-term, optimum-dose iloprost treatment of severe pulmonary hypertension associated with systemic sclerosis (SSc) and the primary antiphospholipid syndrome (APS). Methods. Three patients with SSc and 2 with APS who had